Compare iShares iBoxx $ Inv Grade Corporate Bond ETF (LQD) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares iBoxx $ Inv Grade Corporate Bond ETF vs Tempus AI — how do they compare? iShares iBoxx $ Inv Grade Corporate Bond ETF trades at $105.99, while Tempus AI trades at $55.5 (market cap $9.93B). The key difference: Tempus AI is trading nearer its 52-week high, iShares iBoxx $ Inv Grade Corporate Bond ETF nearer its low. Which is the better fit depends on your goals.
| LQD | TEM | |
|---|---|---|
52-Week High | $112.91 | $103.25 |
52-Week Low | $105.96 | $41.55 |
Market Cap | — | $9.93B |
Sector | — | Broad Market / Factor |
Enterprise Value | — | $10.56B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
LQD trades at $106.55, showing modest daily gains of 0.18% amid a bearish technical outlook with moving averages signaling caution. The ETF maintains consistent dividend distributions, with recent payments ranging from $0.38 to $0.46 per share. Market sentiment reflects uncertainty around Federal Reserve policy and inflation trends, with bond yields fluctuating based on oil price movements and geopolitical tensions.
Investment opportunities include exposure to investment-grade corporate bonds with regular income distribution, while risks center on interest rate sensitivity and macroeconomic volatility. The fund's performance remains tied to credit market conditions and Federal Reserve policy decisions, with technical indicators suggesting near-term pressure despite neutral oscillator readings.
Tempus AI (TEM) trades at $52.05, up 12.86% in 24 hours, reflecting strong momentum after Q2 2026 earnings beat revenue estimates and raised 2026 sales guidance. The stock is technically bullish with moving averages supporting upside, while fundamentals show revenue growth to $1.4 billion in 2026 but persistent net losses. Recent news highlights expansion through the Personalis acquisition and AI-driven precision medicine advancements.
Outlook: Growth prospects are robust with AI adoption in healthcare and strategic deals, but high valuation ratios and negative profitability pose risks. Analysts are bullish with a $61.57 consensus target, though cash burn and competitive pressures require monitoring for sustained investor confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares iBoxx $ Inv Grade Corporate Bond ETF
The fund will invest at least 80% of its assets in the component securities of the underlying index, and it will invest at least 90% of its assets in fixed income securities of the types included in the underlying index that the advisor believes will help the fund track the underlying index. The underlying index is designed to provide a broad representation of the US dollar-denominated liquid investment-grade corporate bond market.
Read more on LQD →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
